BitePRO Report Record Sales Of Bite Resistant Clothing Due To ... - 13 January 2021 02:11

WETHERBY, England, Jan. 13, 2021 /PRNewswire-AsiaNet/ -- British bite resistant clothing producer BitePRO [https://www.bite-pro.com/] have reported record sales, as violence against teachers continues to be a regular occurrence in schools around the world. Wherever consistent statistics exist, these ...

  Medical Microinstruments Appoints Healthcare Industry Veteran ... - 13 January 2021 02:00

CALCI, Italy, Jan. 12, 2021 /PRNewswire-AsiaNet/ -- Toland joins Andrew Cleeland (Chairman of the Board, MMI) in developing the field of robotic-assisted microsurgery Medical Microinstruments (MMI) SpA[https://www.mmimicro.com/], a robotics company dedicated to improving clinical outcomes for pa...

  Caprion-HistoGeneX Expands its Histological Biomarker Franchis... - 13 January 2021 00:20

MONTREAL, Jan. 13, 2021 /PRNewswire-AsiaNet/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners ("Arsenal"), announced today the acquisition of Mosaic Laboratories LLC ("Mosaic"), a California-based company offering histolog...

  DarwinHealth Scientists Publish Foundational Research Identify... - 12 January 2021 11:30

NEW YORK, Jan. 12, 2021 /PRNewswire-AsiaNet/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the January 11, 2021 online publication in Cell of a landmark paper, "A Modular Master Regulator Landscape Controls Cancer Transcriptional Identity,"(1,...

  Announcing Calyx: Advancing Clinical Research Through Technolo... - 11 January 2021 22:05

NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire-AsiaNet/ -- -- Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider Calyx ( https://www.calyx.ai/?utm_campaign=discover&utm_source=newswire&utm_medium=referral&utm_content=0111-pr ), a leadin...

  Standigm and SK Chemicals Repurpose FDA-approved Drug into Rhe... - 11 January 2021 10:00

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire-AsiaNet/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...

  Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines... - 07 January 2021 20:00

DARMSTADT, Germany, Jan. 7, 2021 /PRNewswire-AsiaNet/ -- - Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA ...

  INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Tr... - 07 January 2021 00:00

PLYMOUTH MEETING, Pa., Jan. 6, 2021 /PRNewswire-AsiaNet/ -- -- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment -- Phase 2 results indicate that...

  RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation... - 06 January 2021 23:44

TEL AVIV, Israel and RALEIGH, NC, Jan. 6, 2021 /PRNewswire-AsiaNet / -- U.S. Phase 3 study underway to evaluate RHB-204 as a first-line, stand-alone, oral treatment for pulmonary NTM disease - a rare condition with no FDA-approved first-line therapy FDA Fast Track designation, together with previously granted QIDP...

  Eleva Secures up to EUR 60 million to Advance a Drug Candidate... - 06 January 2021 20:00

FREIBURG, Germany, January 6, 2021, /PRNewswire-AsiaNet/-- Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from v...